EWA
ONC

Evolution Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Evolution Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-86
Closed -$14K – 662
2019
Q4 		$14K Buy
86
+79
+1,129% +$13.1K ﹤0.01% 259
2019
Q3 		$1K Sell
7
-74
-91% -$9.83K ﹤0.01% 471
2019
Q2 		$10K Buy
+81
New +$10.3K ﹤0.01% 178

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Evolution Wealth Advisors's ONC Position: Q1 2020 in Review

Evolution Wealth Advisors sold out of BeOne Medicines Ltd (ONC) in Q1 2020, closing a stake of 86 shares — an estimated $14K sold.

Evolution Wealth Advisors first reported a position in ONC in Q2 2019 and held it in 3 quarters. The position peaked at $14K in Q4 2019. 215 funds tracked by Wall St. Rank hold ONC as of Q1 2020.

  • Evolution Wealth Advisors reported no remaining BeOne Medicines Ltd position as of Q1 2020 after selling out during the quarter.
  • Evolution Wealth Advisors sold 86 BeOne Medicines Ltd shares in Q1 2020, an estimated $14K.
  • Evolution Wealth Advisors first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 3 quarters.
  • Evolution Wealth Advisors's BeOne Medicines Ltd position peaked at $14K in Q4 2019.
  • 215 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2020.

Based on Evolution Wealth Advisors's 13F filing for Q1 2020, filed 22 Apr 2020.